JP2006513992A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513992A5 JP2006513992A5 JP2004543586A JP2004543586A JP2006513992A5 JP 2006513992 A5 JP2006513992 A5 JP 2006513992A5 JP 2004543586 A JP2004543586 A JP 2004543586A JP 2004543586 A JP2004543586 A JP 2004543586A JP 2006513992 A5 JP2006513992 A5 JP 2006513992A5
- Authority
- JP
- Japan
- Prior art keywords
- inclusion
- polymer
- polymer composition
- linker molecule
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 claims 28
- 239000000203 mixture Substances 0.000 claims 26
- 150000001875 compounds Chemical group 0.000 claims 8
- 229920000249 biocompatible polymer Polymers 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical group O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 6
- 230000000975 bioactive effect Effects 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 239000012867 bioactive agent Substances 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 229940124597 therapeutic agent Drugs 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 229920000858 Cyclodextrin Polymers 0.000 claims 2
- 229920006037 cross link polymer Polymers 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 229920001184 polypeptide Polymers 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 239000000651 prodrug Chemical group 0.000 claims 2
- 229940002612 prodrug Drugs 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 241000700605 Viruses Species 0.000 claims 1
- 206010052428 Wound Diseases 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000012752 auxiliary agent Substances 0.000 claims 1
- 229920002988 biodegradable polymer Polymers 0.000 claims 1
- 239000004621 biodegradable polymer Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 102000004169 proteins and genes Human genes 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US41737302P | 2002-10-09 | 2002-10-09 | |
| PCT/US2003/031991 WO2004032862A2 (en) | 2002-10-09 | 2003-10-08 | Cyclodextrin-based materials, compositions and uses related thereto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006513992A JP2006513992A (ja) | 2006-04-27 |
| JP2006513992A5 true JP2006513992A5 (https=) | 2006-08-17 |
| JP4602085B2 JP4602085B2 (ja) | 2010-12-22 |
Family
ID=32094010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004543586A Expired - Fee Related JP4602085B2 (ja) | 2002-10-09 | 2003-10-08 | シクロデキストリンを基材とした物質、組成物及びこれらと関連する用途 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US8357377B2 (https=) |
| EP (1) | EP1549269A4 (https=) |
| JP (1) | JP4602085B2 (https=) |
| KR (1) | KR20050051686A (https=) |
| CN (1) | CN1717209A (https=) |
| AU (1) | AU2003295344B2 (https=) |
| BR (1) | BR0315198A (https=) |
| CA (1) | CA2501132A1 (https=) |
| MX (1) | MXPA05003591A (https=) |
| RU (1) | RU2005114007A (https=) |
| TW (1) | TW200423960A (https=) |
| WO (1) | WO2004032862A2 (https=) |
| ZA (1) | ZA200502754B (https=) |
Families Citing this family (65)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0314042B8 (pt) | 2002-09-06 | 2021-05-25 | Calando Pharmaceuticals Inc | polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência |
| WO2004032862A2 (en) | 2002-10-09 | 2004-04-22 | Insert Therapeutics, Inc. | Cyclodextrin-based materials, compositions and uses related thereto |
| SG129240A1 (en) * | 2003-01-23 | 2007-02-26 | Agency Science Tech & Res | Biodegradable copolymer and nucleic acid delivery system |
| US7605120B2 (en) * | 2003-10-22 | 2009-10-20 | Amgen Inc. | Antagonists of the brandykinin B1 receptor |
| US20070020196A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension |
| US20070020298A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid |
| US20070020299A1 (en) * | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| RU2006127432A (ru) | 2003-12-31 | 2008-02-10 | Сайдекс, Инк. (Us) | Ингаляционная композиция, содержащая сульфоалкиловый эфир циклодекстрина и кортикостероид, полученная из единичной дозы суспензии |
| ATE446581T1 (de) * | 2004-03-12 | 2009-11-15 | Trinity College Dublin | Magnetoresistives medium |
| EP1768672A2 (en) * | 2004-07-01 | 2007-04-04 | The Netherlands Cancer Institute | Combination comprising a bcrp inhibitor and 4-(4-methylpiperazin-1-ylmethyl)-n-ý4-methyl-3-(4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide |
| EP1866414B9 (en) | 2005-03-31 | 2012-10-03 | Calando Pharmaceuticals, Inc. | Inhibitors of ribonucleotide reductase subunit 2 and uses thereof |
| JPWO2006115211A1 (ja) * | 2005-04-25 | 2008-12-18 | 株式会社カネカ | シクロデキストリン含有ポリエステル系重合体及びその製造方法 |
| WO2007009265A1 (en) * | 2005-07-22 | 2007-01-25 | The Governors Of The University Of Alberta Tec Edmonton | NOVEL β-CYCLODEXTRIN-BASED MOLECULES AND DRUG DELIVERY COMPOSITIONS |
| US20070160542A1 (en) * | 2005-12-20 | 2007-07-12 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile |
| US20070197486A1 (en) * | 2005-12-20 | 2007-08-23 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids |
| US20070249572A1 (en) * | 2005-12-20 | 2007-10-25 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| US20070178050A1 (en) * | 2005-12-20 | 2007-08-02 | Verus Pharmaceuticals, Inc. | Methods and systems for the delivery of corticosteroids having an increased lung depositon |
| US20070185066A1 (en) * | 2005-12-20 | 2007-08-09 | Verus Pharmaceuticals, Inc. | Systems and methods for the delivery of corticosteroids |
| JP2007211060A (ja) * | 2006-02-07 | 2007-08-23 | Japan Advanced Institute Of Science & Technology Hokuriku | 超分子ポリマー及びその合成方法 |
| JP2009526858A (ja) * | 2006-02-15 | 2009-07-23 | ティカ レーケメデル アーベー | コルチコステロイド溶液を製造する方法 |
| KR100809046B1 (ko) * | 2006-03-10 | 2008-03-03 | 가톨릭대학교 산학협력단 | 풀루란을 가진 나노자가응집체 및 이의 이용방법 |
| US20080027212A1 (en) * | 2006-06-28 | 2008-01-31 | Skinner Keith K | Methods and compositions for improved uptake of biological molecules |
| CN101568351B (zh) * | 2006-12-22 | 2012-05-30 | 3M创新有限公司 | 控制释放的组合物和方法 |
| US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
| AU2008224935B2 (en) | 2007-03-15 | 2013-07-25 | Ventana Medical Systems, Inc. | Stabilized hematoxylin |
| CN101686681B (zh) | 2007-04-27 | 2015-04-01 | 锡德克斯药物公司 | 包含氯吡格雷和磺基烷基醚环糊精的制剂和其使用方法 |
| CA2692021A1 (en) * | 2007-06-28 | 2008-12-31 | Capsutech Ltd | Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers |
| US12370352B2 (en) | 2007-06-28 | 2025-07-29 | Cydex Pharmaceuticals, Inc. | Nasal and ophthalmic delivery of aqueous corticosteroid solutions |
| ITMI20071321A1 (it) * | 2007-07-04 | 2009-01-05 | Sea Marconi Technologies Di Va | Nanospugne a base di ciclodestrine come veicolo per farmaci antitumorali |
| CN102037123A (zh) | 2008-04-04 | 2011-04-27 | 卡兰多制药股份有限公司 | Epas1抑制剂的组合物和用途 |
| US10463677B2 (en) | 2008-11-07 | 2019-11-05 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
| WO2010088286A1 (en) * | 2009-01-28 | 2010-08-05 | Smartcells, Inc. | Synthetic conjugates and uses thereof |
| US20100197041A1 (en) * | 2009-01-30 | 2010-08-05 | Thomas Hermann | Nucleic acid binding assays |
| CN102414116B (zh) * | 2009-02-26 | 2015-01-21 | 加利福尼亚大学董事会 | 用于制备尺寸可控的纳米颗粒的超分子方法 |
| WO2010132711A1 (en) | 2009-05-13 | 2010-11-18 | Cydex Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
| US11020363B2 (en) | 2009-05-29 | 2021-06-01 | Cydex Pharmaceuticals, Inc. | Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same |
| CA2763365C (en) | 2009-05-29 | 2016-09-13 | Cydex Pharmaceuticals, Inc. | Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same |
| US10045937B2 (en) * | 2009-06-03 | 2018-08-14 | Case Western Reserve University | Therapeutic agent delivery system and method |
| IN2012DN02345A (https=) | 2009-09-16 | 2015-08-21 | Univ Duke | |
| ME03396B (me) * | 2009-11-18 | 2020-01-20 | Nektar Therapeutics | Oblici kisele soli konjugata polimer-lek |
| AU2010321533A1 (en) | 2009-11-23 | 2012-05-31 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
| US20110178287A1 (en) | 2010-01-19 | 2011-07-21 | Cerulean Pharma Inc. | Cyclodextrin-based polymers for therapeutic delivery |
| AU2011255647A1 (en) * | 2010-05-18 | 2012-11-15 | Cerulean Pharma Inc. | Compositions and methods for treatment of autoimmune and other diseases |
| US20120213854A1 (en) * | 2010-09-30 | 2012-08-23 | Fetzer Oliver S | Methods of treating a subject and related particles, polymers and compositions |
| JP6013349B2 (ja) | 2010-11-01 | 2016-10-25 | メイ ファーマ, インク.Mei Pharma, Inc. | 癌の処置のためのイソフラボノイド化合物および方法 |
| US10335491B2 (en) * | 2011-07-21 | 2019-07-02 | The Regents Of The University Of California | Catalytic delivery nanosubstrates (CDNS) for highly efficient delivery of biomolecules |
| CN103289075B (zh) * | 2012-02-22 | 2016-01-20 | 天津键凯科技有限公司 | 聚乙二醇与纳洛酮的结合物及其药物组合物和应用 |
| FR2989001B1 (fr) * | 2012-04-06 | 2017-07-21 | Centre Nat Rech Scient | Microparticules et nanoparticules constituees de polysaccharides hydrophobises et d'une alpha-cyclodextrine |
| EP2838653A4 (en) | 2012-04-18 | 2015-11-25 | Cerulean Pharma Inc | Methods and systems for polymer precipitation and generation of particles |
| US9827321B2 (en) | 2012-08-14 | 2017-11-28 | The Trustees Of The University Of Pennsylvania | Stabilizing shear-thinning hydrogels |
| WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| US9828341B2 (en) * | 2012-11-28 | 2017-11-28 | Victoria Link Limited | Dendritic core compounds |
| CN105358136B (zh) * | 2013-02-15 | 2018-11-13 | 加利福尼亚大学董事会 | 超分子磁性纳米粒子 |
| CA2902753C (en) | 2013-02-27 | 2019-04-09 | Crayola Llc | Rinsable inks and methods of making the same |
| DE102013021060A1 (de) * | 2013-12-18 | 2015-06-18 | Rathor Ag | Verfahren zur Abtrennung von Monomeren aus isocyanathaltigen Prepolymeren |
| JP6300926B2 (ja) * | 2014-07-08 | 2018-03-28 | 国立大学法人大阪大学 | 自己修復性を有する高分子材料及びその製造方法 |
| CA2950694C (en) | 2014-07-09 | 2019-04-02 | Halliburton Energy Services, Inc. | Treatment fluids for reducing subterranean formation damage |
| CN116139125A (zh) | 2015-02-02 | 2023-05-23 | 梅制药公司 | 联合治疗 |
| MY189214A (en) | 2015-06-19 | 2022-01-31 | Univ Queensland | Composition |
| CN105999289B (zh) * | 2016-04-01 | 2018-11-20 | 南开大学 | 一种二元超两亲性纳米粒子溶液及其制备方法和应用 |
| CN106349396A (zh) * | 2016-08-26 | 2017-01-25 | 湖南尔康制药股份有限公司 | 一种具有超声敏感性的交联淀粉 |
| US12447464B2 (en) | 2016-12-22 | 2025-10-21 | Duke University | Polycationic microfibers and methods of using the same |
| CN112011040B (zh) * | 2020-07-20 | 2021-08-17 | 广州医科大学 | 一种多重纳米传递系统及其制备方法 |
| EP4192509A1 (en) | 2020-08-05 | 2023-06-14 | Ellipses Pharma Ltd | Treatment of cancer using a cyclodextrin-containing polymer-topoisomerase inhibitor conjugate and a parp inhibitor |
| US20240115709A1 (en) * | 2021-02-25 | 2024-04-11 | Noble Panacea Labs, Inc. | Assembly of organic supramolecular vessels for controlled drug release |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1390479A (en) | 1973-09-05 | 1975-04-16 | I Orch Sinteza Akademii Nauk L | Pharmaceutical composition for treatment of parkinsonism |
| DE2842862A1 (de) | 1978-10-02 | 1980-04-10 | Boehringer Mannheim Gmbh | Verfahren zur bestimmung von ionen, polaren und/oder lipophilen substanzen in fluessigkeiten |
| CH663951A5 (fr) * | 1984-10-10 | 1988-01-29 | Nestle Sa | Procede d'enrichissement selectif en acides gras polyinsatures d'un melange contenant des acides gras fractions enrichies obtenues et compositions les contenant. |
| US4841081A (en) | 1985-10-16 | 1989-06-20 | Osaka Soda Co., Ltd. | Method of optically resolving a racemate or a diastereomeric mixture of glycidyl compound |
| GB2197720A (en) | 1986-11-20 | 1988-05-25 | Nat Res Dev | Immobilisation of polynucleotides |
| EP0362290A4 (en) | 1987-06-17 | 1991-09-25 | Princess Margaret Children's Medical Research Foundation (Inc.) | Cloning of mite allergens |
| US4877778A (en) | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| JP2614081B2 (ja) | 1988-05-27 | 1997-05-28 | 大塚化学株式会社 | 光学活性β−ラクタム誘導体の製造法 |
| US4887778A (en) | 1988-06-01 | 1989-12-19 | Universal Instruments Corporation | Feeder drive assembly and replaceable section for tape supplying and cover peeling |
| HU200913B (en) | 1988-07-28 | 1990-09-28 | Ciklodextrin Kutato Fejlesztoe | Process for producing infusion stock-solution containing pharmaceutically active components of bad water solubility |
| US5098793A (en) * | 1988-09-29 | 1992-03-24 | Uop | Cyclodextrin films on solid substrates |
| US5139687A (en) | 1990-05-09 | 1992-08-18 | The Proctor & Gamble Company | Non-destructive carriers for cyclodextrin complexes |
| JPH0425505A (ja) | 1990-05-21 | 1992-01-29 | Toppan Printing Co Ltd | シクロデキストリンポリマー及びシクロデキストリン膜の製造方法 |
| DE69127810T2 (de) * | 1990-11-30 | 1998-03-12 | Toppan Printing Co Ltd | Verfahren zur herstellung eines cyclodextrinderivates und polymer welches darin immobilisiertes cyclodextrin enthält |
| JP2976154B2 (ja) * | 1991-11-27 | 1999-11-10 | コニカ株式会社 | ハロゲン化銀写真感光材料用固形処理剤 |
| HU210922B (en) | 1993-05-24 | 1995-09-28 | Europharmaceuticals Sa | Nimesulide alkali salt cyclodextrin inclusion complexes their preparation and pharmaceutical compositions containing them |
| US5880154A (en) | 1994-02-01 | 1999-03-09 | The Board Of Regents Of The University Of Nebraska | Polymeric adamantane analogues |
| HU218280B (en) | 1994-04-26 | 2000-07-28 | Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes | |
| US5691316A (en) * | 1994-06-01 | 1997-11-25 | Hybridon, Inc. | Cyclodextrin cellular delivery system for oligonucleotides |
| JP3699141B2 (ja) * | 1994-09-24 | 2005-09-28 | 伸彦 由井 | 超分子構造の生体内分解性医薬高分子集合体及びその調製方法 |
| US5728804A (en) | 1995-06-02 | 1998-03-17 | Research Corporation Technologies, Inc. | Use of cyclodextrins for protein renaturation |
| US6667293B1 (en) | 1995-09-12 | 2003-12-23 | Hybridon, Inc. | Use of cyclodextrins to modulate gene expression with reduced immunostimulatory response |
| DE19629494A1 (de) * | 1996-07-09 | 1998-01-15 | Schering Ag | Pseudopolyrotaxane |
| US5844030A (en) * | 1996-07-09 | 1998-12-01 | Andros; Nicholas | Charged ion cleaning devices and cleaning system |
| JP2001524097A (ja) | 1997-04-23 | 2001-11-27 | ユニバーシティ オブ オタゴ | 眼用組成物の制御放出 |
| JPH11100401A (ja) | 1997-07-30 | 1999-04-13 | Kikkoman Corp | 環状オリゴ糖及びそれを含むレトロウイルス性疾患の予防または治療剤 |
| JP2001516729A (ja) | 1997-09-15 | 2001-10-02 | ジェネティック・イミューナティ・リミテッド・ライアビリティ・カンパニー | 皮膚の抗原提示細胞に遺伝子を運搬する方法 |
| IT1298732B1 (it) | 1998-03-13 | 2000-02-02 | Recordati Chem Pharm | Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione |
| US6048736A (en) * | 1998-04-29 | 2000-04-11 | Kosak; Kenneth M. | Cyclodextrin polymers for carrying and releasing drugs |
| US7091192B1 (en) | 1998-07-01 | 2006-08-15 | California Institute Of Technology | Linear cyclodextrin copolymers |
| US6509323B1 (en) | 1998-07-01 | 2003-01-21 | California Institute Of Technology | Linear cyclodextrin copolymers |
| US6261583B1 (en) * | 1998-07-28 | 2001-07-17 | Atrix Laboratories, Inc. | Moldable solid delivery system |
| US6703381B1 (en) | 1998-08-14 | 2004-03-09 | Nobex Corporation | Methods for delivery therapeutic compounds across the blood-brain barrier |
| DE69935526T2 (de) | 1998-12-04 | 2007-11-22 | California Institute Of Technology, Pasadena | Supramolekulare komplexe enthaltende arzneimittel |
| US7375096B1 (en) | 1998-12-04 | 2008-05-20 | California Institute Of Technology | Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network |
| US6740643B2 (en) | 1999-01-21 | 2004-05-25 | Mirus Corporation | Compositions and methods for drug delivery using amphiphile binding molecules |
| WO2000075164A1 (en) | 1999-06-07 | 2000-12-14 | Mirus Corporation | COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES |
| EP1102784A4 (en) | 1999-06-07 | 2009-12-30 | Mirus Bio Corp | A CONNECTION WITH A LABILES DISULFIDE TIE |
| EP1233671A4 (en) | 1999-11-29 | 2005-11-02 | Mirus Corp | COMPOSITIONS AND METHODS OF DISPOSING MEDICAMENTS USING AMPHIPHILIC BINDING MOLECULARS |
| SK282717B6 (sk) | 2000-03-10 | 2002-11-06 | �Stav Experiment�Lnej Farmakol�Gie Sav | Spôsob prípravy ultravysokomolekulových hyalurónanov |
| AU2001279164A1 (en) | 2000-08-01 | 2002-02-13 | Oregon Health And Science University | Mammalian dna binding membrane-associated protein-encoding gene and uses |
| TWI321054B (en) | 2000-12-19 | 2010-03-01 | California Inst Of Techn | Compositions containing inclusion complexes |
| US7141540B2 (en) * | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
| BRPI0314042B8 (pt) * | 2002-09-06 | 2021-05-25 | Calando Pharmaceuticals Inc | polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência |
| WO2004032862A2 (en) | 2002-10-09 | 2004-04-22 | Insert Therapeutics, Inc. | Cyclodextrin-based materials, compositions and uses related thereto |
| US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
-
2003
- 2003-10-08 WO PCT/US2003/031991 patent/WO2004032862A2/en not_active Ceased
- 2003-10-08 KR KR1020057006045A patent/KR20050051686A/ko not_active Withdrawn
- 2003-10-08 CA CA002501132A patent/CA2501132A1/en not_active Abandoned
- 2003-10-08 US US10/681,745 patent/US8357377B2/en not_active Expired - Fee Related
- 2003-10-08 CN CNA2003801045673A patent/CN1717209A/zh active Pending
- 2003-10-08 RU RU2005114007/04A patent/RU2005114007A/ru not_active Application Discontinuation
- 2003-10-08 AU AU2003295344A patent/AU2003295344B2/en not_active Ceased
- 2003-10-08 MX MXPA05003591A patent/MXPA05003591A/es not_active Application Discontinuation
- 2003-10-08 EP EP03786526A patent/EP1549269A4/en not_active Withdrawn
- 2003-10-08 JP JP2004543586A patent/JP4602085B2/ja not_active Expired - Fee Related
- 2003-10-08 BR BR0315198-0A patent/BR0315198A/pt not_active IP Right Cessation
- 2003-10-09 TW TW092128118A patent/TW200423960A/zh unknown
-
2005
- 2005-04-05 ZA ZA200502754A patent/ZA200502754B/en unknown
-
2012
- 2012-12-06 US US13/707,217 patent/US20130315980A1/en not_active Abandoned
-
2013
- 2013-08-15 US US13/968,112 patent/US20140199370A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006513992A5 (https=) | ||
| Abourehab et al. | Recent advances of chitosan formulations in biomedical applications | |
| RU2005114007A (ru) | Материалы на основе циклодекстринов, их композиции и применение | |
| Li et al. | Tailoring materials for modulation of macrophage fate | |
| Zhao et al. | Advanced bioactive nanomaterials for biomedical applications | |
| Rial-Hermida et al. | Recent progress on polysaccharide-based hydrogels for controlled delivery of therapeutic biomolecules | |
| Yang et al. | Nanostructured antimicrobial peptides: crucial steps of overcoming the bottleneck for clinics | |
| Ding et al. | Weak bond-based injectable and stimuli responsive hydrogels for biomedical applications | |
| Law et al. | Peptide-based biomaterials for protease-enhanced drug delivery | |
| EP2087910B1 (en) | Polymeric prodrugs | |
| Kulkarni et al. | Peptide-chitosan engineered scaffolds for biomedical applications | |
| RU2010137743A (ru) | Конъюгированные молекулы фактора viii | |
| Galanakou et al. | Amphiphilic dendrimers against antibiotic resistance: light at the end of the tunnel? | |
| JP2010524849A5 (https=) | ||
| WO2005028516A3 (en) | Albumin-binding derivatives of therapeutic peptides | |
| HRP20041108B1 (hr) | Peptidi povezani sa tumorom koji se vežu na mhc molekule | |
| JP2013517226A5 (ja) | ウイルス、バクテリア、寄生生物に感染した細胞及び／又は腫瘍細胞に影響を及ぼす生物学的有効分子群、及び該分子群を適用するための方法 | |
| CN107744593B (zh) | 一种叶酸靶向抗肿瘤药物缓释载体及其制备方法 | |
| Jia et al. | Bottlebrush polymer-conjugated melittin exhibits enhanced antitumor activity and better safety profile | |
| Hu et al. | Mechanisms of hydrogel-based microRNA delivery systems and its application strategies in targeting inflammatory diseases | |
| Li et al. | Peptide‐based nanoarchitectonics for the treatment of liver fibrosis | |
| Hegde et al. | An update on design and pharmacology of dendritic poly (l-lysine) | |
| Xu et al. | Antisenescence ZIF-8/Resveratrol nanoformulation with potential for enhancement of bone fracture healing in the elderly | |
| CN1503679A (zh) | 形成自聚集体的抗癌药-脱乙酰壳多糖复合体以及其制备方法 | |
| CN1694728B (zh) | 用于传递治疗剂的以环糊精为基础的聚合物 |